เพื่อพัฒนาเว็บไซต์ให้ดียิ่งขึ้น โปรดสละเวลา 1 นาที ในการตอบแบบสอบถามจากเรา Click !!

บุคลากรอาจารย์อาวุโส


รศ.ดร.ภก. อาทร ริ้วไพบูลย์

รศ.ดร.ภก. อาทร ริ้วไพบูลย์

arthorn.rie@mahidol.ac.th

arthorn.rie@mahidol.ac.th
อาจารย์ประจำภาควิชาเภสัชกรรม

ผลงานวิจัยตีพิมพ์

2021

  1. Antibiotic use evaluation using WHO methodology in a private hospital, Yangon, Myanmar
    Maung H, Riewpaiboon A, Chanjaruporn *F. Pharmaceutical Sciences Asia 2021; 48(3): 269-276.

  2. Cost analysis of influenza vaccination for pregnant women in Thailand
    Riewpaiboon A*. Pharmaceutical sciences asia 2021; 48(2) : 99-106.

  3. Cost of premature mortality attributable to smoking in the Middle East and North Africa
    Nagi M, Riewpaiboon A, Thavorncharoensap M*. Eastern Mediterranean Health Journal 2021; 27(10): 974-983.

  4. Cost-effectiveness analysis of diagnostic tests for para-aortic lymph node detection in locally advanced cervical cancer
    Katanyoo K, Chaikledkaew U*, Thavorncharoensap M, Riewpaiboon A. Clinicoecon Outcomes Res 2021; 13: 943-955.

  5. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi
    Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Vaccine 2021; 39(8) :1272-1282.

  6. Economic burden of childhood diarrhea in Burundi
    Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Global Health Research and Policy 2021; 6(1): 13.

  7. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand
    Rochanathimoke O, Riewpaiboon A, Praditsitthikorn N, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ. Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(4): 811-819.

  8. Health seeking behavior and experiences related to HIV treatment of people living with HIV (PLHIV) in Yangon, Myanmar
    Aung HNY, Riewpaiboon A, Sunantiwat M, Hone S, Thavorncharoensap M*. Pharmaceutical Sciences Asia 2021; 48(4): 320-329.

  9. The Cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis
    Katanyoo K, Riewpaiboon A*, Chaikledkaew U, Thavorncharoensap M. Asian Pacific Journal of Cancer Prevention 2021; 22(10): 3171-3179.

  10. Unit cost analysis of medical service in asia: A systematic review
    Dianingati RS, Riewpaiboon A*. Pharmaceutical sciences asia 2021; 48(2) : 185-193.


2020

  1. Assessing the outcomes of farmers on promoting herbal medicine use
    Kwankhao P, Indaratna K, Anuratpanich L, Riewpaiboon A*. Pharmaceutical sciences asia 2020; 47(1): 43-50.


2019

  1. Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand
    Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Epidemiology and infection 2019; 147: e133.

  2. Cost analysis in health promotion, disease prevention and controlling program in Asia: A systematic review
    Riewpaiboon A*, Dianingati RS. Pharmaceutical Sciences Asia 2019; 46(3); 163-174.

  3. Cost analysis of pilot school-based HPV vaccination program in two provinces of Lao PDR
    Riewpaiboon A*, Pathammavong C, Fox K, Hutubessy R. Pharmaceutical Sciences Asia 2019; 46(1): 46-53.

  4. Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination
    Rochanathimoke O, Riewpaiboon A*, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ. Vaccine 2019; 37(4): 587-594.

  5. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand
    Phodha T, Riewpaiboon A*, Malathum K, Coyte PC. Expert Review of Pharmacoeconomics and Outcomes Research 2019;19(3):305-312

  6. Treatment cost and costing model of obstetric complications at a hospital in Myanmar
    Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S. PLoS ONE 2019;14(3):e0213141


2018

  1. A comparison of EQ-5D-3L index scores using Malaysian, Singaporean, Thai, and UK value sets in Indonesian cervical cancer patients
    Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Value in Health Regional Issues 2018; 15: 50-55.

  2. Development of Relative Value Units for Unit Cost analysis of Medical Services in Vietnam
    Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): s19-s26

  3. Estimating the economic impact of canine rabies to Viet Nam 2005-2014
    Shwiff S.A., Brown V.R., Dao T.T., Elser J., Trung H.X., Tien N.N., Huong N.T., Huong N.T.T., Riewpaiboon A., Ernst K., Shwiff S., Payne D. PLoS neglected tropical diseases 2018; 12(10): e0006866

  4. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand
    Phodha T., Riewpaiboon A*., Malathum K., Coyte P.C. Expert Review of Pharmacoeconomics and Outcomes Research 2018; (Article in Press)

  5. Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand
    Rochanathimoke O, Riewpaiboon A, Postma MJ, Thinyounyong W, Thavorncharoensap M.* Expert Review of Pharmacoeconomics and Outcomes Research 2018; 18(2): 215-222

  6. Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand
    Siritho S., Thavorncharoensap M., Chanatittarat C., Pasogpakdee P., Apiwattanakul M., Prayoonwiwat N., Chankrachang S., Riewpaiboon A., Chaikledkaew U. Multiple Sclerosis and Related Disorders 2018; 24: 151-156.

  7. Hospital cost analysis in developing countries: A methodological comparison in Vietnam
    Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): S8-S18.

  8. Knowledge, attitude, practice (KAP) and health related quality of life of priests with type 2 diabetes mellitus in Thailand
    Rajbhandari S, Riewpaiboon A, Peradhammanon P, Rattanaphanit S, Chanjaruporn F.* Pharmaceutical Sciences Asia 2018; 45(2): 93-104

  9. Modelling the health economic impact of influenza vaccination strategies for high-risk children in Vietnam
    Vo T.Q., Chaikledkaew U., Van Hoang M., Riewpaiboon A. Journal of Clinical and Diagnostic Research 2018; 12(6): LC26-LC32.

  10. National reference unit cost of health-care services: International experiences
    Vo T.Q., Van Hoang M., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): s27-s37


2017

  1. Cost of Acute Care For Ischemic Stroke in Thailand
    Sribundit N*, Riewpaiboon A, Chaikledkaew U, Stewart JF, Tantirittisak T, Hanchaipiboolkul S. Southeast Asian Journal of Tropical Medicine and Public Health 2017; 48(3): 628-640.

  2. Cost of pneumonia in children: A systematic review
    Sirisuksan V, Trung QV, Riewpaiboon A*. Pharmaceutical Sciences Asia 2017; 44 (1): 40-49

  3. Economic burden of influenza at a tertiary hospital in Vietnam
    Vo TQ, Chaikledkaew U, Hoang MV, Riewpaiboon A.* Asian Pacific Journal of Tropical Disease 2017; 7(3): 144-150

  4. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy
    Tharmaphornpilas P*, Jiamsiri S, Boonchaiya S, Rochanathimoke O, Thinyounyong W, Tuntiwitayapun S, Guntapong R, Riewpaiboon A, Rasdjarmrearnsook A-O, Glass RI. Vaccine 2017; 35(5): 796-801

  5. Health seeking behavior and its determinants in Jaffna Sri Lanka
    Kalki P, Thavorncharoensap M, Riewpaiboon A*. Pharmaceutical Sciences Asia 2017; 44(3): 134-141

  6. Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam
    Quang Vo T, Chaikledkaew U, van Hoang M, Riewpaiboon A*. ClinicoEconomics and Outcomes Research 2017; 9: 423-432

  7. The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review
    Setiawan D*, Oktora MP, Hutubessy R, Riewpaiboon A, Postma MJ. Expert Review of Vaccines 2017; 16(9): 933-943.


2016

  1. Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam
    Riewpaiboon A*, Shin S, Le TP, Vu DT, Nguyen TH, Alexander N, Dang DA. BMC Public Health 2016; 16(1).

  2. Effect of costing methods on unit cost of hospital medical services; A case of capital cost
    Riewpaiboon A*, Rajbhandari S, Coyte PC. Mahidol University Journal of Pharmaceutical Sciences 2016; 43 (2): 97-105

  3. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy
    Tharmaphornpilas P., Jiamsiri S., Boonchaiya S., Rochanathimoke O., Thinyounyong W., Tuntiwitayapun S., Guntapong R., Riewpaiboon A., Rasdjarmrearnsook A.-O., Glass R.I. Vaccine 2016; 35(5): 796-801.

  4. Healthcare costing studies in developing countries: A systematic review in Vietnam
    Vo TQ, Chaikledkaew U, Van Hoang M, Riewpaiboon A*. International Journal of Pharmaceutical Sciences Review and Research 2016; 39(2): 295-299.

  5. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey
    Dorji C, Tragulpiankit P*, Riewpaiboon A, Tobgay T. Drug Safety 2016; 39(12): 1239-1250.

  6. Setting priorities for introducing new vaccines into the national immunization program; a systematic review
    Pooripussarakul S, Riewpaiboon A*. Mahidol University Journal of Pharmaceutical Sciences 2016; 43 (3): 135-142.

  7. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
    Pooripussarakul S, Riewpaiboon A*, Bishai D, Muangchana C, Tantivess S. BMC Public Health 2016; 16(1): 684.


2015

  1. Evaluation of Health-Related Quality of Life among Patients with Cervical Cancer in Indonesia
    Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Asian Pacific of Journal Cancer Prevention 2015; 16(8): 3345-3350

  2. Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan
    Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Drug Safety 2015; 38(10): 946-946

  3. Optimizing national immunization program supply chain management in Thailand: An economic analysis
    Riewpaiboon A*, Sooksriwong C, Chaiyakunapruk N, Tharmaphornpilas P, Techathawat S, Rookkapan K, Rasdjarmrearnsook A, Suraratdecha C. Public Health 2015; 129(7): 899-906


2014

  1. Burden of care for persons with disabilities in Vietnam
    Riewpaiboon A*, Van Minh H, Huong NT, Dung P, Wright EP. Health and Social Care in the Community 2014; 22(6): 660-671

  2. Cost of illness due to typhoid fever in Pemba, Zanzibar, East Africa
    Riewpaiboon A*, Piatti M, Ley B, Deen J, Thriemer K, von Seidlein L, SalehJiddawi M, Busch CJ-L, Schmied WH, Ali SM, Pak G, Ochiai LR, Puri MK, Chang NY, Wierzba TF, Clemens JD. Journal of Health, Population and Nutrition 2014; 32(3): 377-385

  3. Health-Related Quauity of life in Patients with Cervical Cancer in Indonesia
    Endarti D*, Riewpaiboon A, Thavorncharoensap M. Value in Health 2014; 17(7): 738-739

  4. Measurement of costs for health economic evaluation.
    Riewpaiboon A. J Med Assoc Thai. 2014; 97(5) :S17-26.

  5. Quality of Life of Diarrheal Children and Caregivers in Thailand
    Rochanathimoke O*, Postma M, Thavorncharoensap M, Riewpaiboon A, Thinyounyong W. Value in Health 2014; 17(7): 368-369

  6. Standard cost lists for health economic evaluation in Thailand.
    Riewpaiboon A. J Med Assoc Thai. 2014; 97(5) :S127-34.


2013

  1. Economic evaluations of hepatitis A vaccination in middle-income countries
    Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu H-AT, Postma MJ*. Expert Review of Vaccines 2013; 12(12): 1479-1494

  2. Management of childhood asthma and role of pharmacist.
    Pooripussarakul S, Riewpaiboon A*. Mahidol University Journal of Pharmaceutical Sciences 2013; 40(1): 18-27.

  3. สวัสดิการสังคมและการดูแลสุขภาพอย่างไม่เป็นทางการ: กรณีศึกษาการใช้การประเมินค่าทางเศรษฐศาสตร์ในการกำหนดเงินค่าชดเชยในประเทศไทย
    วัชรา ริ้วไพบูลย์, กันยารัตน์ ปนสูงเนิน, ซัสมิทา แชทเทอร์จี, อาทร ริ้วไพบูลย์. วารสารวิจัยระบบสาธารณสุข 2013; 7(1) : 86-98


2012

  1. Antimicrobial resistance(AMR) in Thailand: A systematic review.
    Phodha T*, Riewpaiboon A, coyte PC, Thamlikitkul V. Value in Health 2012; 15: A602-A681.

  2. Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand
    Muangchana C, Riewpaiboon A*, Jiamsiri S, Thamapornpilas P, Warinsatian P. Vaccine 2012; 30(18): 2839-2847

  3. Economic evaluation of vaccination in southeast asian countries: a systematic review.
    Endarti D*, Riewpaiboon A. Value in Health 2012; 15: A602-A681.

  4. Standard cost list for economic evaluation in Thailand.
    Riewpaiboon A* Value in Health 2012; 15: A602-A681.

  5. ผลกระทบต้านสุขภาพและเศรษฐศาสตร์จากการติดเชื้อดื้อยาต้านจุลชีพในประเทศไทย : การศึกษาเบื้องต้น
    ภาณุมาศ ภูมาศ, ตวงรัตน์ โพธะ, วิษณุ ธรรมลิขิตกุล, อาทร ริ้วไพบูลย์, ภูษิต ประคองสาย, สุพล ลิมวัฒนานนท์ วารสารวิจัยระบบสาธารณสุข 2012; 6(3): 352-360.


2011

  1. Cost analysis for efficient management: Diabetes treatment at a public district hospital in Thailand
    Riewpaiboon A, Chatterjee S*, Piyauthakit P. International Journal of Pharmacy Practice 2011; 19(5): 342-349

  2. Cost analysis for reimbursement-rate setting of hospital pharmaceutical services in Thailand
    Riewpaiboon A*, Kumluang S. International Journal of Pharmacy Practice 2011; 19(5): 333-341

  3. Cost of diabetes and its complications in Thailand: A complete picture of economic burden
    Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W, Boupaijit K, Panpuwong N, Archavanuntagul V. Health and Social Care in the Community 2011; 19(3): 289-298

  4. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-saharan Africa [Rentabilité de l"artésunate parentéral administer" chez les enfants gravement atteints de paludisme en Afrique subsaharienne]
    Lubell Y*, Riewpaiboon A, Dondorp AM, Von Seidlein L, Mokuolu OA, Nansumba M, Gesase S, Kent A, Mtove G, Olaosebikan R, Ngum WP, Fanello CI, Hendriksen I, Day NP, Whitea NJ, Yeungk S. Bulletin of the World Health Organization 2011; 89(7): 504-512

  5. Disability and cost for diabetic patients at a public district hospital in Thailand
    Riewpaiboon A, Chatterjee S*, Riewpaiboon W, Piyauthakit P. International Journal of Pharmacy Practice 2011; 19(2): 84-93.

  6. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand
    Praditsitthikorn N*, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V. PharmacoEconomics 2011; 29(9): 781-806

  7. ต้นทุนผู้ป่วยรายบุคคลสำหรับกลุ่มวินิจฉัยโรคร่วมประเทศไทย: วิธีต้นทุนจุลภาค
    อรทัย เขียวเจริญ, ศุภสิทธิ์ พรรณารุโณทัย, ชัยโรจน์ ซึงสนธิพร, อาทร ริ้วไพบูลย์ วารสารวิชาการสาธารณสุข 2011; 20(4): 572-585.


2010

  1. Budget impact of the thalassemia management under the national health security scheme in Thailand
    Riewpaiboon A*, Bunyadharokul S, Chaikledkaew U, Torcharus K. Mahidol J Pharm. Sci 2010; 37(1-2): 28-39.

  2. Cost-effectiveness analysis of home rehabilitation programs for Thai stroke patients
    Sritipsukho P, Riewpaiboon A, Chaiyawat P, Kulkantrakorn K. J Med Assoc Thai 2010;93 Suppl 7:S262-70.

  3. Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children.
    Riewpaiboon A*, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol BO. BMC Res Notes 2010; 3:29.

  4. Factors affecting health-related quality of life in Thai children with thalassemia.
    Thavorncharoensap M*, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. BMC Blood Disord 2010; 10: 1.

  5. Treatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Nam
    Dang DA, Riewpaiboon A*, Le HT, Kim SA, Nyambat B, Kilgore P. J Health Popul Nutr. 2010; 28(5): 436-442.


2009

  1. Economic evaluations of hepatitis B vaccination for developing countries
    Tu H-AT, Woerdenbag HJ, Kane S, Riewpaiboon A, Van Hulst M, Postma MJ*. Expert Rev Vaccines 2009; 8(7): 907-920.

  2. Economic valuation of informal care in Asia: A case study of care for disabled stroke survivors in Thailand
    Riewpaiboon A*, Riewpaiboon W, Ponsoongnern K, Van den Berg B. Soc Sci Med 2009; 69(4): 648-653.

  3. How the blind cope with problems of medicine utilization: a study in Bangkok, Thailand
    Riewpaiboon A*. Pharmacoepidem Dr S 2009; 18(8): 708-12.

  4. Potential cost-effectiveness of a rotavirus immunization program in rural China
    Wang X-Y*, Riewpaiboon A, Von Seidlein L, Chen X-B, Kilgore PE, Ma J-C, Qi S-X, Zhang Z-Y, Hao Z-Y, Chen J-C, Xu Z-Y. Clin Infect Dis 2009; 49(8): 1202-1210.

  5. Treatment cost of typhoid fever at two hospitals in Kolkata, India.
    Sur D, Chatterjee S*, Riewpaiboon A, Manna B, Kanungo S, Bhattacharya SK. J Health Pop Nutr 2009; 27(6): 725-32.


2008

  1. A cost function analysis of shigellosis in Thailand.
    Riewpaiboon A, Youngkong S, Sreshthaputra N, Stewart JF, Samosornsuk S, Chaicumpa W, von Seidlein L, Clemens JD Value Health 2008;11 (Suppl 1) Mar: S75-S83.

  2. A drug cost model for injuries due to road traffic accidents
    Riewpaiboon A, Piyauthakit P, Srijariya W, Chaikledkaew U Pharmacy Practice. 2008; 6(1) Jan: 9-14.

  3. Economic burden of road traffic injuries: A micro-costing approach
    Riewpaiboon A, Piyauthakit P, Chaikledkaew U Southeast Asia J Trop Med Public Health 2008; 39(6): 1139-1149.

  4. Measurement of costs
    Riewpaiboon A J Med Assoc Thai 2008; 91 (Suppl.2): S28-S37

  5. Predicting the treatment cost of bacterial diarrhoea at a regional hospital in Thailand
    Riewpaiboon A, Intraprakarn K, Phoungkatesunthorn S J Health Pop Nutr 2008; 26(4): 442-50

  6. The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries.
    Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Riewpaiboon A Vaccine 2008;26:6305-16


2007

  1. Diabetes cost model of a hospital in Thailand
    Riewpaiboon A*, Pornlertwadee P, Pongsawat K. Value Health 2007; 10(4) Jul:223-30.

  2. Effect of costing methods on unit cost of hospital medical services
    Riewpaiboon A*, Malaroje S, Kongsawatt S. Tropical Medicine and International Health 2007; 12(4) Apr: 554-63

  3. Informal care of disabled stroke survivors: a case study in Thailand.
    Riewpaiboon W, Riewpaiboon A, Ponsoongnern K, Bernard Van den Berg Bull Dept Med Serv. 2007; 32(4): 473-85


2006

  1. Increasing herbal product consumption in Thailand
    Riewpaiboon A*. Pharmacoepidemiology and Drug Safety 2006; 15(9): 683-686


2005

  1. Cost structure of hospital-based pharmaceutical services: a consideration of reimbursement
    Riewpaiboon A, Jaroenkitpan N, Wipaswacharayotin Y Mahidol J Pharm Sci 2005; 32 (3-4): 47-54

  2. Increasing Herbal Product Consumption in Thailand
    Riewpaiboon A Pharmacoepidemiology and Drug Safety 2005; 15: 683-6


2004

  1. Unit costs of medical services at Prasart Neurological Institute
    Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W Srinakharinwirot J Pharm Sci 2004; 9(1): 52-8


2002

  1. Cost of cerebral infarction in societal perspective
    Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W. Srinakharinwirot J Pharm Sci 2002; 7(1): 95-105

  2. การวิจัยสมุนไพรด้านเศรษฐศาสตร์ กรอบแนวคิดและสถานการณ์ในประเทศไทย
    อาทร ริ้วไพบูลย์ วารสารวิชาการสาธารณสุข 2545; 11(4): 545-61


2001

  1. Practice of herbal counseling of community pharmacists in Thailand
    Riewpaiboon A, Janewitvichaikul N and Pongcharoensuk P Pharmacoepidemiology and Drug Safety 2001; 10 (supplement): S45

  2. Quality Predictors of Traditional Drugs Produced in Thailand.
    Riewpaiboon A, Temsiririrkkul R, Chulasiri M Mahidol J Pharm Sci 2001; 28(1-4): 17-27


1999

  1. A proposal for an incentive scheme for promoting rational antibiotic use
    Riewpaiboon A, Sunderiand VB, Tangcharoensathien V, Paamore PR Mahidol J Pharm Sci 1999; 25(2): 36-43

  2. Antimicrobial use evaluation
    Riewpaiboon A and Sunderland VB Frontiers in Plant Science 1999; 26(1-4): 44-51

  3. Cost-benefit analysis of an incentive scheme for promoting antibiotic prescribing
    Riewpaiboon A,Sunderland VB,Tangcharoensathien V,Passmore PR Pharmacoepidemiology and Drug Safety 1999; 8 (Suppl 2): S141-2


1998

  1. Increasing appropriate antibiotic prescribing in a Thai regional hospital by an innovative incentive scheme
    Riewpaiboon A, Sunderland VB, Sirinavin S, Tangcharoensathien V, Kongpatanakul S, Passmore PR Pharmacoepidemiology and Drug Safety 1998; 7 (Suppl 2): S186-7


1994

  1. Physical Quality Evaluation on Traditional Tablets Registered in Thailand
    Riewpaiboon A Mahidol J Pharm Sci 1994; 21(1): 22-31


1993

  1. The Study on Using Medicinal Plants for Self-Treatment of Diabetes Mellitus Patients Attended at Community Hospitals in Nakhonpathom Province
    Riewpaiboon A, Chuakul W, Riewpaiboon A, et al. Bull Dept Med Serv 1993; 18: 232-8

  2. การใช้สมุนไพรของผู้ป่วยเบาหวาน ที่มารับบริการที่โรงพยาบาลชุมชนในจังหวัดนครปฐม.
    อาทร ริ้วไพบูลย์, วัชรา ริ้วไพบูลย์, วงศ์สถิตย์ ฉั่วกุล, คนอื่นๆ. วารสารกรมการแพทย์ 2536; 18: 232-8


1988

  1. Constituents of Paramichelia baillonii. Three new Germacranolides
    Ruangrungsi N, Riewpaiboon A, Lange GL, Decices CP J Nat Prod 1988; 51(1): 163-7


1987

  1. Constituents of Paramichelia baillonii: A New Germacranolide Alkaloid
    Ruangrungsi N, Riewpaiboon A, Lange GL, Picha P, Decices CP J Nat Prod 1987; 50(8): 891-6



หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ รศ.ดร.ภก. อาทร ริ้วไพบูลย์ ได้แก่ อาทร ริ้วไพบูลย์ ; Riewpaiboon A ;

คณะเภสัชศาสตร์ มหาวิทยาลัยมหิดล

447 ถนนศรีอยุธยา แขวงทุ่งพญาไท เขตราชเทวี กรุงเทพฯ 10400

ดูเบอร์ติดต่อหน่วยงานต่างๆ | ดูข้อมูลการเดินทางและแผนที่

เว็บไซต์นี้ออกแบบและพัฒนาโดย งานเทคโนโลยีสารสนเทศและสื่อการเรียนการสอน คณะเภสัชศาสตร์ มหาวิทยาลัยมหิดล
Copyright © 2013-2024
 

เว็บไซต์นี้ใช้คุกกี้

เราใช้เทคโนโลยีคุกกี้เพื่อช่วยให้เว็บไซต์ทำงานได้อย่างถูกต้อง การเปิดให้ใช้คุณสมบัติทางโซเชียลมีเดีย และเพื่อวิเคราะห์การเข้าเว็บไซต์ของเรา การใช้งานเว็บไซต์ต่อถือว่าคุณยอมรับการใช้งานคุกกี้